Sources claim that mRNA vaccines are far from the only path as a Covid-19 therapeutic…
Join The True Defender Telegram Chanel Here: https://t.me/TheTrueDefender
Now we are receiving reports that a drug approved nearly 70 years ago may be effective at suppressing or fighting severe Covid-19 symptoms according to a recent study performed on the drug.
“Researchers dosed the mice with disulfiram a day before and three hours after infecting them with the virus that causes COVID-19. Some 95 % of those mice survived, compared to 40 % not treated with the drug.
The new study and a previous one that linked disulfiram with the reduced NET formation and improved survival “suggest that disulfiram could be useful in the management of pathologies involving NETs, including lung injuries, sepsis, thrombosis, and cancer,” the researchers said in the paper, which was published by The Journal of Clinical Investigation on Feb. 8,” The Epoch Times reported.
Happy to share that we found FDA-approved Disulfiram to be an effective way to block NET-formation in vivo in two independent preclinical models of lung injury (TRALI and SARS-CoV-2 infection), leading to increased survival and reduced lung damage. https://t.co/fSOccIMWEC
— Jose M. Adrover (@niseto) February 8, 2022
‘disulfiram’ protected rodents from immune-mediated lung injury in 2 separate models of this type of injury: infection with SARS-CoV-2 & a lung failure syndrome called TRALI –
Old Drug May Have New Trick: Protecting Against COVID-19 Lung Injury https://t.co/nExX0Htqmh
— dkmurray (@sanccie26) February 10, 2022
Disulfiram (FDA-approved) prevents immune system from producing toxic webs known as neutrophil extracellular traps (NETs) and could protect lungs during covid infection.
Clinical trials in symptomatic patients are underwayhttps://t.co/IIlAptlieG
— Laurence Bettle (@LaurenceBettle) February 10, 2022